Comprehensive Solutions For Animal Health Biologics

Aragen Life Sciences offers a comprehensive suite of services tailored to protein science, cell line development, and process development. Their expertise spans from gene-to-GMP solutions, with a strong focus on developing over 200 cell lines, including for canine and feline mAbs and fusion proteins, and using royalty-free CHO-DG44 and CHO-GS platforms for high-titer production.

Their analytics capabilities include various techniques such as antibody-antigen binding affinity, enzyme activity assays, and advanced methods like SEC-MALS and CE-SDS. The company also provides single-use bioreactors with capacities ranging from 50L to 250L, ideal for preclinical applications, GLP studies, and research. Process development services are driven by automated systems like the Ambr® 250 Bioreactors, ensuring higher titers and efficient timelines.

In addition, Aragen is preparing for GMP manufacturing with scalability options in drug substance production, including bioreactor capacities up to 2,000L. Learn more by downloading the brochure below.